Ipsen

This study tested the drug cabozantinib in 127 people with advanced kidney cancer that had gotten worse after initial treatment with immunotherapy. The goal was to see if cabozantinib could shrink tumors or slow the cancer's growth. Participants took cabozantinib pills, and resea…

This study tested two different chemotherapy combinations in 770 people with advanced pancreatic cancer that had not been treated before. One group received a new liposomal form of irinotecan plus other standard drugs, while the other group received a standard combination of nab-…

This study tested a single injection of triptorelin pamoate that lasts 6 months in 195 Chinese men with advanced or metastatic prostate cancer. The goal was to lower testosterone to castrate levels, which helps control cancer growth. The treatment was effective and safe, offering…

This study tested two muscle-relaxing injections, Dysport and Botox, in 464 adults with arm stiffness (spasticity). The goal was to see if Dysport is as safe as Botox and whether it keeps muscles relaxed for a longer time. Participants received both treatments at different times,…

This study tested a wearable sensor (ADAM) to objectively measure scratching and sleep patterns in 30 adults with primary biliary cholangitis (PBC), a rare liver disease that causes intense itching and sleep problems. Participants wore the sensor for 7 nights over four 7-day peri…

This study followed 831 men aged 60 and older with prostate cancer who were starting hormone therapy (GnRH agonists). Researchers tracked changes in quality of life over six months, comparing different age groups. The goal was to understand how this common treatment affects older…

This study looked at whether a device called GripAble can help track how well botulinum toxin injections work for people with arm stiffness after a stroke or brain injury. Sixteen adults used the tool at home to measure their grip strength and movement. The goal was to see if Gri…

This study looked at how moderate and severe liver impairment changes the way the body handles a single dose of the drug palovarotene. Researchers compared 31 participants with liver problems to healthy volunteers. The goal was to understand safety and drug levels in the blood, n…